David Matthew Friedman

Insider Reports History

Location: New York, NY
Signature: /s/ Douglas Carlson
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Matthew Friedman:

Form 4 holding Director

Veradermics, Inc

Security class: Stock Option (Right to Buy)
Shares / value: 43,000
Estimated value
Report date: 03 Feb 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by David Matthew Friedman

3 AVLN

Avalyn Pharma Inc.

Report period: 29 Apr 2026
Transactions: 0
Transaction value: $0
Filing time: 29 Apr 2026, 18:39
Role: Director
Next action: Open filing details

4 MANE

Veradermics, Inc

Report period: 03 Feb 2026
Transactions: 1
Transaction value: $0
Filing time: 05 Feb 2026, 19:04
Role: Director
Next action: Open filing details

3 MANE

Veradermics, Inc

Report period: 03 Feb 2026
Transactions: 0
Transaction value: $0
Filing time: 03 Feb 2026, 21:06
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .